RDIF and Morepen Laboratories announce production of the test batch of Sputnik V in India
RDIF and Morepen Laboratories announce production of the test batch of Sputnik V in India: The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), and Morepen Laboratories, one of the leading manufacturers of pharmaceutical products in India, today announced the production of the test batch of the Russian Sputnik V coronavirus vaccine in an exclusive facility in state of Himachal Pradesh (HP).

Comments
Post a Comment